Upsher-Smith launches cyclosporine ophthalmic emulsion
“The launch of cyclosporine ophthalmic emulsion reflects Upsher-Smith’s continued momentum in expanding and diversifying its U.S. portfolio.”
Upsher-Smith
Upsher-Smith launches Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP
First prescription ear drop suspension advances portfolio diversification strategy.
Upsher-Smith launches KYMBEE (deflazacort) Tablets
Company reinforces commitment to rare disease community through its Promise of Support Program.